Vivanza Biosciences Ltd.BSE: VIVANZA

Vivanza Biosciences Ltd. Press Release Feb 12 2026

· Issued by Vivanza Biosciences Ltd. via BSE India

Filed with BSE ·

Pursuant to regulation 32 of SEBI (Listing Obligation and Disclosure Requirements, 2015, read with SEBI Circular No. CIR/CFD/CMD1/162/2019 dated 24th December, 2019 regarding submission of Statement of Deviation or Variation from proceeds of Public issue/right issue/preferential issue, Qualifed Institutions Placement,(QIP) etc, we hereby confirm that the Company has not raised any further funds by means of Public issue, Rights issue, or preferential Issue, etc. Hence, the statement of Deviation(s) or Variation(s) is not being provided as it is not applicable to the Company

View Attachment

6ix hasn’t read this filing yet.

Vivanza Biosciences Ltd. on 6ix

Earlier from Vivanza Biosciences

Later from Vivanza Biosciences

All Vivanza Biosciences news releases